TeehanB.P., ReichardG.A., SiglerM.H., SchleiferC.R., CupitM.C., HaffA.C.: Acid-Base Studies in Continuous Ambulatory Peritoneal Dialysis.in CAPD Update.MoncriefJ.W., PopovichR.P. (eds): New York, Masson Publishing, 95–102, 1982.
11.
RobsonM., PintoT., KaoE., OrenA.: The Metabolism of Lactate and Bicarbonate in CAPD, in AtkinsR.C., ThomsonN.M., FarrellP.C. (eds): Peritoneal Dialysis.Edinburgh, Churchill Livingstone Publishers, 211–216, 1981.
12.
MillerF.N., NolphK.D., JoshuaI.G., WiegmanD.L., HarrisP.D., AndersonD.B.: Hypersomolality, Acetate and Lactate: Dilatory Factors During Peritoneal Dialysis.Kidney Int.20: 397–402, 1981.
13.
RubinJ., NolphK.D., ArafaniaD., WiegmanD.L., MillerF.N., HarrisP.D.: Comparison of the Effects of Lactate and Acetate on Clinical Peritoneal Clearances.Clin. Nephrol.12: 145–147, 1979.
14.
NolphK.D., RubinJ., WeigmanD.L., HarrisP.D., MillerF.N.: Peritoneal Clearances with Three Types of Commercially Available Peritoneal Dialysis Solutions.Nephron24: 35–40, 1979.
15.
NolphK.D., ProwantB., SerkesK.D..: Multicenter Evaluation of a New Peritoneal Dialysis Solution with a High Lactate and a Low Magnesium Concentration.Perit. Dial. Bull.3: 63–66, 1983.
16.
MandelbaumJ.M., HeistandM.L., SchardinK.E.: Six Months’ Experience with PD-2 Solution.Dialysis & Transplant12: 259–260, 1983.